Lupin Bags First US Rival To $1.6bn Ingrezza – But Launch Will Have To Wait

Firm Receives First And So Far Only FDA Approval For Valbenazine 40mg And 80mg Capsules

 
• By Dave Wallace
  
US flag thumbs up
Lupin received FDA approval for the first Ingrezza rival • Source: Shutterstock

More from Products

More from Generics Bulletin